Stefan Wohlfeil

715 total citations
18 papers, 581 citations indexed

About

Stefan Wohlfeil is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stefan Wohlfeil has authored 18 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stefan Wohlfeil's work include Cancer, Lipids, and Metabolism (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Food Allergy and Anaphylaxis Research (2 papers). Stefan Wohlfeil is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Food Allergy and Anaphylaxis Research (2 papers). Stefan Wohlfeil collaborates with scholars based in Germany, United Kingdom and Czechia. Stefan Wohlfeil's co-authors include J Belkner, Hartmut Kühn, F Morich, D. Neuser, Lennart Nathell, Enno Hartmann, Johannes Peter Stasch, S. Kazda, Helga Ruebsamen‐Waigmann and Jürgen Stoltefuß and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Physiology and FEBS Letters.

In The Last Decade

Stefan Wohlfeil

18 papers receiving 566 citations

Peers

Countries citing papers authored by Stefan Wohlfeil

Since Specialization

Citations

This map shows the geographic impact of Stefan Wohlfeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Wohlfeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Wohlfeil more than expected).

Fields of papers citing papers by Stefan Wohlfeil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Wohlfeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Wohlfeil. The network helps show where Stefan Wohlfeil may publish in the future.

Co-authorship network of co-authors of Stefan Wohlfeil

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Wohlfeil. A scholar is included among the top collaborators of Stefan Wohlfeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Wohlfeil. Stefan Wohlfeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Pharmacokinetics, Pharmacodynamics and Bioavailability of ACM‐001.1 (S‐Pindolol Benzoate) in Healthy Volunteers 2024 ·Journal of Cachexia Sarcopenia and Muscle ·Frank Misselwitz, Dennis R. Henderson, (unknown), (unknown), (unknown), (unknown), Stefan Wohlfeil, John McDermott	2
2	Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures 2019 ·Drug Safety ·Lennart Nathell, (unknown), Stefan Wohlfeil	28
3	Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017 2018 ·Drug Safety ·B. Ehlken, Lennart Nathell, (unknown), (unknown), Massoud Toussi, Stefan Wohlfeil	23
4	Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model 2002 ·Antiviral Research ·Olaf Weber, (unknown), Enno Hartmann, (unknown), (unknown), (unknown), Karl Deres, Siegfried Goldmann, (unknown), Jürgen Stoltefuß, Dieter Haebich, Helga Ruebsamen‐Waigmann, Stefan Wohlfeil	141
5	Comparison of the Effects of the Thrombin Inhibitor r-Hirudin in Four Animal Models of Neointima Formation After Arterial Injury 1996 ·Arteriosclerosis Thrombosis and Vascular Biology ·Christoph Gerdes, (unknown), Özkan Yalkinoglu, Stefan Wohlfeil	33
6	A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia. 1996 ·PubMed ·Giso Feussner, Jürgen Dobmeyer, Hermann-Josef Gröne, Stefan Lohmer, Stefan Wohlfeil	29
7	Elevation of Circulating NO: Its Effects on Hemodynamics and Vascular Smooth Muscle Cell Proliferation in Rats 1995 ·Birkhäuser Basel eBooks ·(unknown), (unknown), Stefan Wohlfeil	3
8	Induction ofC-FOSExpression in Rat Vascular Smooth Muscle Reporter Cells by Selective Activation of the Thrombin Receptor 1995 ·Journal of Receptors and Signal Transduction ·(unknown), P. Spreyer, Martin Bechem, Heiner Apeler, Stefan Wohlfeil	4
9	A 10 BP deletion in the apolipoprotein ε gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia 1995 ·Atherosclerosis ·Giso Feussner, Jürgen Dobmeyer, Stefan Lohmer, Stefan Wohlfeil	3
10	Involvement of 15-lipoxygenase in early stages of atherogenesis. 1994 ·The Journal of Experimental Medicine ·Hartmut Kühn, J Belkner, (unknown), (unknown), Stefan Wohlfeil	164
11	Biosynthesis of 18-Hydroxydeoxycorticosterone and Corticosterone in Adrenal Tissue of Rat Strains with Salt-Dependent Hypertension 1988 ·Clinical and Experimental Hypertension Part A Theory and Practice ·Stefan Wohlfeil, D. Neuser, F Morich	6
12	Increased tubuloglomerular feed‐back mediated suppression of glomerular filtration during acute volume expansion in rats. 1988 ·The Journal of Physiology ·John M. Davis, (unknown), T. Kawata, E. Schmitt, T. Takabatake, Stefan Wohlfeil	12
13	The Renal Response to Acute Hypervolemia Is Caused by Atrial Natriuretic Peptides 1987 ·Survey of Anesthesiology ·(unknown), J.-P. Stasch, (unknown), S. Kazda, F Morich, D. Neuser, Stefan Wohlfeil	7
14	Blockade of the response to volume expansion by monoclonal antibodies against atrial natriuretic peptides. 1987 ·PubMed ·(unknown), (unknown), S. Kazda, (unknown), F Morich, D. Neuser, Stefan Wohlfeil	12
15	α‐h‐ANP is the only form of circulating ANP in humans 1987 ·FEBS Letters ·(unknown), (unknown), F Morich, D. Neuser, Wolfgang P. Schröder, J.-P. Stasch, Stefan Wohlfeil	11
16	The Renal Response to Acute Hypervolemia is Caused by Atrial Natriuretic Peptides 1986 ·Journal of Cardiovascular Pharmacology ·(unknown), Johannes Peter Stasch, (unknown), S. Kazda, F Morich, D. Neuser, Stefan Wohlfeil	78
17	α-hANP Is the Only Circulating Form of ANP in Human Plasma 1986 ·Journal of Cardiovascular Pharmacology ·(unknown), (unknown), F Morich, (unknown), W. Schröder, J.-P. Stasch, Stefan Wohlfeil	1
18	The elevation of cyclic GMP as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides 1986 ·European Journal of Pharmacology ·Johannes‐Peter Stasch, (unknown), S. Kazda, Stefan Wohlfeil	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact